期刊
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 59, 期 38, 页码 16381-16384出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.202005111
关键词
ferroptosis; immunogenic cell death; immunotherapy; manganese oxide; nanovaccines
资金
- National Natural Science Foundation of China
- NSFC [51720105015, 51672269, 51929201, 51922097, 51772124, 51872282]
- Science and Technology Cooperation Project between Chinese and Australian Governments [2017YFE0132300]
- Key Research Program of Frontier Sciences, CAS [YZDY-SSW-JSC018]
- Youth Innovation Promotion Association of CAS [2017273]
Despite the widespread applications of manganese oxide nanomaterials (MONs) in biomedicine, the intrinsic immunogenicity of MONs is still unclear. MnO(x)nanospikes (NSs) as tumor microenvironment (TME)-responsive nanoadjuvants and immunogenic cell death (ICD) drugs are proposed for cancer nanovaccine-based immunotherapy. MnO(x)NSs with large mesoporous structures show ultrahigh loading efficiencies for ovalbumin and tumor cell fragment. The combination of ICD via chemodynamic therapy and ferroptosis inductions, as well as antigen stimulations, presents a better synergistic immunopotentiation action. Furthermore, the obtained nanovaccines achieve TME-responsive magnetic resonance/photoacoustic dual-mode imaging contrasts, while effectively inhibiting primary/distal tumor growth and tumor metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据